Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens-Reference-Cited by-同舟云学术

Deciphering minimal antigenic epitopes associated with Burkholderia pseudomallei and Burkholderia mallei lipopolysaccharide O-antigens

Published:2017-07-24 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Tamigney Kenfack Marielle,Mazur Marcelina,Nualnoi Teerapat,Shaffer Teresa L.,Ngassimou Abba,Blériot Yves,Marrot Jérôme,Marchetti Roberta,Sintiprungrat Kitisak,Chantratita Narisara,Silipo Alba,Molinaro Antonio,AuCoin David P.,Burtnick Mary N.,Brett Paul J.,Gauthier Charles

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-00173-8.pdf

Reference70 articles.

1. Wiersinga, W. J., van der Poll, T., White, N. J., Day, N. P. & Peacock, S. J. Melioidosis: insights into the pathogenicity of Burkholderia pseudomallei. Nat. Rev. Microbiol. 4, 272–282 (2006).

2. Currie, B. J. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin. Respir. Crit. Care. Med. 36, 111–125 (2015).

3. Limmathurotsakul, D. et al. Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat. Microbiol 1, 1–5 (2016).

4. Khan, I. et al. Glanders in animals: a review on epidemiology, clinical presentation, diagnosis and countermeasures. Transbound. Emerg. Dis. 60, 204–221 (2013).

5. Wagar, E. Bioterrorism and the role of the clinical microbiology laboratory. Clin. Microbiol. Rev. 29, 175–189 (2016).

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study of the protease inhibitory activity component of SARS-CoV-2 3CL in Bletilla striata;Frontiers in Natural Products;2024-03-28

2. Burkholderia pseudomallei Complex Subunit and Glycoconjugate Vaccines and Their Potential to Elicit Cross-Protection to Burkholderia cepacia Complex;Vaccines;2024-03-15

3. Structural characterization of a nonionic rhamnolipid from Burkholderia lata;Carbohydrate Research;2024-01

4. Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines;ACS Infectious Diseases;2023-01-27

5. Cross reacting material (CRM197) as a carrier protein for carbohydrate conjugate vaccines targeted at bacterial and fungal pathogens;International Journal of Biological Macromolecules;2022-10